Similarly, gene expression of ROPN1 and ROPN1B was also commonly detected in a melanoma patient cohort accessed via the TCGA (ROPN1: 98.9%, ROPN1B: 98.7% vs. CTAG1B: 68.2%). This evidence concerns the gene ROPN1B and melanoma.